0001562180-24-004761.txt : 20240606
0001562180-24-004761.hdr.sgml : 20240606
20240606174303
ACCESSION NUMBER: 0001562180-24-004761
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240604
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VERNON W ANTHONY
CENTRAL INDEX KEY: 0001369091
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 241026589
MAIL ADDRESS:
STREET 1: C/O AXOVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-06-04
false
0001645113
NovoCure Ltd
NVCR
0001369091
VERNON W ANTHONY
C/O NOVOCURE INC.
1550 LIBERTY RIDGE DRIVE, SUITE 115
WAYNE
PA
19087
true
false
false
false
false
Ordinary Shares
2024-06-04
4
S
false
964.00
23.893
D
164833.00
D
Restricted Stock Units
2024-06-05
4
A
false
4053.00
0.00
A
169850.00
D
Stock Option (Right to Buy)
23.13
2024-06-05
4
A
false
6229.00
0.00
A
2034-06-04
Ordinary Shares
6229.00
6229.00
D
This transaction was executed in multiple trades at prices ranging from $23.78 USD to $24.00 USD; the price reported above reflects the weighted average sale price.
These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
Ovie Onobrakpeya, as attorney in fact for Vernon, W. Anthony
2024-06-06